US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Melodiol Global Health Ltd (ME1O) 銘柄情報

Melodiol Global Health Ltd (ME1O)

0.001

0.00

(0.00%)

終了 6月12日 3:00PM

Melodiol Global Health Ltd (ME1O) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 0.00

発行済株式数

13,099,868

配当利回り

PER

-0.02

1 株当たり利益 (EPS)

-11.28

歳入

18.92M

純利益

-52.45M

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business.... Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

melodiolglobalhealth.com

本社

Nedlands, Australia

設立

2026

Melodiol Global Health Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker ME1O. The last closing price for Melodiol Global Health was AUD0. Over the last year, Melodiol Global Health shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Melodiol Global Health currently has 13,099,868 shares in issue. The market capitalisation of Melodiol Global Health is AUD13,099.87 . Melodiol Global Health has a price to earnings ratio (PE ratio) of -0.02.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

ME1O - Frequently Asked Questions (FAQ)

What is the current Melodiol Global Health Ltd share price?

The current share price of Melodiol Global Health Ltd is AUD 0.001

How many Melodiol Global Health Ltd shares are in issue?

Melodiol Global Health Ltd has 13,099,868 shares in issue

What is the market cap of Melodiol Global Health Ltd?

The market capitalisation of Melodiol Global Health Ltd is AUD 13.1k

What is the 1 year trading range for Melodiol Global Health Ltd share price?

Melodiol Global Health Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Melodiol Global Health Ltd?

The price to earnings ratio of Melodiol Global Health Ltd is -0.02

What is the cash to sales ratio of Melodiol Global Health Ltd?

The cash to sales ratio of Melodiol Global Health Ltd is 0.12

What is the registered address of Melodiol Global Health Ltd?

The registered address for Melodiol Global Health Ltd is 145 Stirling Highway, Nedlands, Western Australia, 6009

What is the Melodiol Global Health Ltd website address?

The website address for Melodiol Global Health Ltd is melodiolglobalhealth.com

Which industry sector does Melodiol Global Health Ltd operate in?

Melodiol Global Health Ltd operates in the Pharmaceuticals sector

ace65

What do you make of this again today major takedown then straight back up again

peafunke

peafunke 52秒前

That’s why I was a little agitated yesterday with you (apologies). It’s not what they have claimed it would be. At all. And they are playing game sworn app updates and not updating the version number. I will give it to next week to see where this is and then I may sour more.

1plus1

here it goes 800 shares trades

Mrt33

Buy this stock and you will regret it.

NorthPeak22

NorthPeak22 2分前

SPCX is still halted since the opening bell but SPCL, a 2X daily leveraged ETF of SPCX is freely trading 😂 Weird

Runners123

Runners123 2分前

RUBI been killing itslowly

Genz2

Methinks, if Trump thinks he is going to be a tough negotiator on a Wave deal, Steven might say something like,”Well you know Donald, Samsung could activate Wave at anytime, and you might want to visit us on the incredible Sez Us platform that could have Scrambls, microtransactions, and a whole host

Vexari

Sworn evidence that mRNA “vaccines” are military bioweapons

old.bitchute.com/video/1dkz3xYfRdAP/ In his affidavit

Boyle called the COVID injections “franken-shots”

That included

Pentagon and DARPA nanotechnology

Designe

LA4321

....100 sh.........ZERO awareness.....ZERO credibility ...........imho-------this is NOT the "ceo" for a public company.

AugustaFriends

AugustaFriends 3分前

$RITR needs to break .91 cents !!

https://stockcharts.com/sc3/ui/?s=RITR

seve333

seve333 3分前

If they did regain compliance they never did a PR on it so my guess is they did not.

shoondale

shoondale 3分前

24 Filed: 7/24/2008, Entered: None Court Filing
STIPULATION AND ORDER: It is hereby stipulated and agreed by and between the parties that all claims asserted by plaintiff in the above captioned action against the dismissed defendants are dismissed in their entirety without prejudice in accord

PennyMillions852

PennyMillions852 3分前

LMAO-Soon-Tommorow-Next Week- same story here week and week....month after month...One tick up and folks thought it was GO time!! Comical!!!

William777

William777 3分前

My experience with writing government contracts and marketing nutritional products helps me understand how branding works and also what gets companies in trouble. JB knows how to get hold of me if he needs a sounding board. I would not be able to convey any conversation I might have with JB or relat

NorthPeak22

NorthPeak22 3分前

I do bc his reply to me is listed in my inbox. Plus he put a bear emoji which is a reference to Owen Benjamin, the guy in the video I posted.

Susie924

Susie924 3分前

Ok thanks. I don’t remember doing that but I will take yours and Shelley’s word for it.

Trooperstocks

Trooperstocks 4分前

$LBRG News: Ladybug Resource Group Launches AI-Driven "Smart Supply Chain Hub," Redefining Global Sourcing for Non-Standard Industrial Components

TULSA, OK – June 12, 2026 (NEWMEDIAWIRE) – Ladybug Resource Group, Inc. (“Ladybug” or the “Company”) (OTC ID: LBRG) today announced the off

PennyRookie0

PennyRookie0 4分前

Last I saw him he was sitting in a folding chair under an interstate bridge.

bas2020

bas2020 4分前

Line 673 in the NHS High-Cost Drugs List... GBM was changed to CANCER several months ago...

https://www.england.nhs.uk/wp-content/uploads/2017/04/nhs-england-high-cost-drugs-list-26-27-v21.0.xlsx

MURCIDENCEL CANCER NHS ENGLAND ATMP NOT ROUTINELY COMMISSIONED AS PER I

glenn1919

glenn1919 4分前

RUBI..................OTLK.............................https://stockcharts.com/sc3/ui/?s=OTLK&p=w&yr=1&mn=3&dy=0&id=p96837884856

seve333

seve333 5分前

It is comical at this point that they actually think fluff pr after fluff pr still works. Shows what they really have which is basically nothing.

KevGee59

KevGee59 5分前

Exactly! If they knew that the MHRA is going to approve, they should tell us. If they don't know, there is no Insider Information.

Trooperstocks

Trooperstocks 5分前

$LBRG News: Ladybug Resource Group Launches AI-Driven "Smart Supply Chain Hub," Redefining Global Sourcing for Non-Standard Industrial Components

TULSA, OK – June 12, 2026 (NEWMEDIAWIRE) – Ladybug Resource Group, Inc. (“Ladybug” or the “Company”) (OTC ID: LBRG) today announced the off

Investor082

Investor082 6分前

I was one of the first ones to highlight that NWBO will get conditional approval. Do you view that as negative?

Although, given how long the saga has taken, the best case scenario is a restrictive label at this stage and no NICE support for at least a couple of years. It appears that

KenKong

KenKong 6分前

Melodiol Global Health

Intesa Sanpaolo

Uniroyal Global Engineer... (EM)

Newport Gold (ID)

Thomson-Reuters

Accsys Technologies

Xtrackers MSCI EM Latin ...

iNAV db xtrackers S & P ...

Heartland Financial USA

Primoris Services

State Street SPDR Bloomb...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。